[Case Study 1, Screen 2: 1000 nurses' notes, vital signs, prescriptions, and IV access.] Which action should the nurse take?
CLIENT
63-year-old woman. Weight 70 kg.
History: type 2 diabetes (takes metformin), hypertension (takes lisinopril).
Lives with spouse; independent in all activities; baseline fully oriented.
Home blood pressure readings usually about 132/78 mm Hg.
NURSES' NOTES - 0800
Spouse reports the client has been "sleepy and confused" since last night.
Client reports burning on urination for 3 days and has been eating and
drinking very little for 2 days. Oriented to person only. Skin warm and
flushed; mucous membranes dry. Reports right flank pain, 5/10. Lungs clear
bilaterally. Capillary refill 3 seconds. Last voided a small amount of dark
urine early this morning.
VITAL SIGNS - 0800
Temperature 39.0°C (102.2°F)
Heart rate 116/min
Respiratory rate 24/min
Blood pressure 88/50 mm Hg (MAP 63 mm Hg)
SpO2 95% on room air
LABORATORY RESULTS - 0815 Result Reference range
WBC 18,600/mm³ 5,000-10,000/mm³
Bands 14% 0-5%
Lactate 4.1 mmol/L 0.5-2.0 mmol/L
Creatinine 1.9 mg/dL 0.5-1.1 mg/dL
(baseline 1 month ago: 0.9 mg/dL)
BUN 40 mg/dL 7-20 mg/dL
Glucose (random) 238 mg/dL 70-140 mg/dL
Sodium 137 mEq/L 135-145 mEq/L
Potassium 4.6 mEq/L 3.5-5.0 mEq/L
Platelets 172,000/mm³ 150,000-400,000/mm³
Urinalysis: cloudy; nitrite positive; leukocyte esterase positive;
WBC more than 50/hpf
NURSES' NOTES - 1000
Blood cultures x2 drawn at 0820. Piperacillin-tazobactam IV started at 0835.
Lactated Ringer's solution 2,100 mL IV completed at 0955. Client is lethargic
but arousable. Extremities cool. Indwelling urinary catheter inserted at 0830;
25 mL of urine since insertion.
VITAL SIGNS - 1000
Temperature 38.6°C (101.5°F)
Heart rate 124/min
Respiratory rate 26/min
Blood pressure 80/44 mm Hg (MAP 56 mm Hg)
SpO2 94% on room air
PROVIDER PRESCRIPTIONS - 1000
- Norepinephrine continuous IV infusion; titrate to maintain MAP at or
above 65 mm Hg.
- Central venous catheter insertion when the provider is available
(estimated 1 to 2 hours).
IV ACCESS
- 18-gauge peripheral IV, right upper forearm (proximal, below the elbow
crease): patent, no redness or swelling.
- 20-gauge peripheral IV, dorsum of left hand: patent.
- AHold the norepinephrine until the central venous catheter has been inserted.
- BStart the norepinephrine through the 18-gauge right proximal forearm IV and monitor the site closely.
- CStart the norepinephrine through the 20-gauge left hand IV so the forearm line remains available for other infusions.
- DInfuse another 2,000 mL of lactated Ringer's solution and hold the norepinephrine until it is complete.
Show answer and explanations
Answer
B
A: Waiting for central access can prolong dangerous hypotension. B: An 18-gauge IV in a proximal upper-forearm vein, away from flexion sites, permits prompt vasopressor initiation with close site monitoring while central access is arranged. C: Peripheral vasopressors are best given through a large-bore IV in a larger, more proximal vein; a smaller 20-gauge IV in the hand is a distal site with higher extravasation risk. D: An automatic extra large bolus before vasopressor therapy can delay needed support and needs reassessment.
A
Waiting for central access can prolong dangerous hypotension.
B
An 18-gauge IV in a proximal upper-forearm vein, away from flexion sites, permits prompt vasopressor initiation with close site monitoring while central access is arranged.
C
Peripheral vasopressors are best given through a large-bore IV in a larger, more proximal vein; a smaller 20-gauge IV in the hand is a distal site with higher extravasation risk.
D
An automatic extra large bolus before vasopressor therapy can delay needed support and needs reassessment.
